FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only.

Press Release/Announcement

FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only.

February 3, 2021

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; January 15, 2021.

Vinca alkaloid misadministration is a persistent problem that results in patient harm and death. This alert raises awareness of label changes that aim to mitigate accidental spinal administration of the high-alert chemotherapy agent by supporting infusion bag administration only.

Free full text

Related Resources From the Same Author(s)

Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling.

February 10, 2021

Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death.

February 20, 2013

Implantable infusion pumps in the magnetic resonance (MR) environment: FDA safety communication—important safety precautions.

January 25, 2017

Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose.

January 19, 2011

FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older.

February 7, 2018

Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings.

February 17, 2021

Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling.

May 19, 2021

Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication.

October 20, 2021

Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11.

September 1, 2021

FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy.

August 20, 2021

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

Wear face masks with no metal during MRI exams.

December 16, 2020

FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder.

August 5, 2020

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents.

July 15, 2020

Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up.

October 19, 2022

FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor).

August 12, 2015

Relenza (zanamivir) inhalation powder.

October 21, 2009

Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology.

October 21, 2009

Tamiflu (oseltamivir) for oral suspension: potential medication errors.

October 7, 2009

Hydrocodone bitartrate and acetaminophen tablets, phenobarbital tablets by Qualitest: recall—incorrect package labeling.

February 16, 2011

FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safety―emphasizing that accidental exposure to used patches can cause death.

October 9, 2013

Important change to heparin container labels to clearly state the total drug strength.

December 19, 2012

Kadcyla (ado-trastuzumab emtansine): drug safety communication—potential medication errors resulting from name confusion.

May 15, 2013

Hospira Carpuject pre-filled cartridges—drug alert: products may contain more than the intended fill volume.

May 30, 2012

Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays.

November 7, 2012

FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management.

November 28, 2018

FDA Safety Communication: recommendations to reduce surgical fires and related patient injury.

June 20, 2018

ReliOn insulin syringes for use with U-100 insulin (Tyco Healthcare-Covidien).

November 19, 2008

Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors.

February 21, 2007

Important Warnings and Instructions for Heparin Sodium Injection (Baxter).

February 20, 2008

Roxane Laboratories initiates a nationwide voluntary recall of a single manufacturing lot of Azathioprine tablets in the U.S. and Puerto Rico.

July 26, 2006

FDA public health notification: unretrieved device fragments.

January 30, 2008

Nimodipine Capsules (marketed as Nimotop).

March 1, 2006

Computerized Prescriber Order Entry Medication Safety (CPOEMS): Uncovering and Learning From Issues and Errors.

January 13, 2016

Five Medication Safety Tips for Older Adults.

February 15, 2024

Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens.

April 8, 2009

Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment.

June 2, 2021

Using ventilator splitters during the COVID-19 pandemic--letter to health care providers.

February 17, 2021

Infections associated with reprocessed flexible bronchoscopes.

September 30, 2015

FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients.

March 11, 2015

Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning.

March 4, 2015

Luer Connector Misconnections: Under-Recognized but Potentially Dangerous Events.

August 15, 2012

My Medicines.

July 9, 2014

Maalox Total Relief and Maalox Liquid Products: Medication Use Errors.

March 3, 2010

Public Health Notification from FDA: Vail Products Enclosed Bed Systems.

December 19, 2007

Drug Shortages: Root Causes and Potential Solutions.

November 13, 2019

Use duodenoscopes with innovative designs to enhance safety: FDA Safety Communication.

May 4, 2022

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering.

April 17, 2019

Making Medical Devices Safer at Home.

January 9, 2013

Safety Problems With Your Child's Medical Device?

July 31, 2013

A Review of FDA’s Approach to Medical Product Shortages.

November 16, 2011

Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health.

June 6, 2018

FDA Funding Available for Research Aimed at Reducing Preventable Harm from Medication

November 6, 2019

FDA 101: How to Use the Consumer Complaint System and MedWatch.

June 25, 2008

Important information for the safe use of Tussionex Pennkinetic Extended-Release Suspension.

March 26, 2008

An Introduction to the Improved FDA Prescription Drug Labeling.

November 1, 2006

FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing.

February 24, 2022 - February 24, 2022

FDA preliminary public health notification: unpredictable events in medical equipment due to new daylight savings time change.

January 9, 2005

FDA Pharmacists Help Consumers Use Medicines Safely.

November 19, 2014

FDASIA Health IT Report: Proposed Strategy and Recommendations for a Risk-Based Framework.

April 30, 2014

Strategic Plan for Preventing and Mitigating Drug Shortages.

November 13, 2013

Accidental exposures to fentanyl patches continue to be deadly to children.

July 21, 2021

Fentanyl transdermal system (marketed as Duragesic) information.

July 10, 2015

Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products.

January 13, 2021

Best Practices in Developing Proprietary Names for Human Prescription Drug Products Guidance for Industry.

December 23, 2020

Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors: Guidance for Industry.

May 25, 2022

Safety Considerations for Product Design to Minimize Medication Errors: Guidance for Industry.

January 9, 2013

Safety considerations to mitigate the risks of misconnections with small-bore connectors intended for enteral applications.

March 4, 2015

Heparin-containing medical devices and combination products: recommendations for labeling and safety testing. Draft guidance for industry and Food and Drug Administration staff.

August 5, 2015

Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff.

October 3, 2022

Reporting of death in US Food and Drug Administration medical device adverse event reports in categories other than death.

August 11, 2021

Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples.

October 7, 2021

Use purple bracelets or wristbands only for do not resuscitate status - letter to industry.

August 25, 2021

Medication Safety During the COVID-19 Pandemic: What Have We Learned in the United States.

June 23, 2020

Postmarket Drug Safety Information for Patients and Providers.

November 19, 2008

Questions and Answers on FDA's Adverse Event Reporting System (FAERS).

September 17, 2008

FDA and ISMP Lists of Look-Alike Drug Names With Recommended Tall Man Letters.

January 26, 2023

Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.

March 3, 2010

Human Factors and Medical Devices.

March 27, 2005

Potential for false positive results with antigen tests for rapid detection of SARS-CoV-2--letter to clinical laboratory staff and health care providers.

November 11, 2020

FDA Drug Safety Communication: FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved.

January 13, 2016

OpenFDA.

June 11, 2014

Be an Active Member of Your Health Care Team.

May 21, 2014

Drug Shortages.

April 27, 2011

Reprocessing of Reusable Medical Devices.

January 11, 2012

Lock it Up: Medicine Safety in Your Home.

November 30, 2011

BeSafeRx: Know Your Online Pharmacy.

October 10, 2012

Teaching Kids About Using Medicine Safely.

February 29, 2012

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

October 10, 2018

FDA MedWatch and Patient Safety Tutorial.

December 10, 2008

MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

June 22, 2005

FDA Guidance Document: Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment.

June 7, 2006

Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment.

March 22, 2006

Technology and error-prevention strategies: why are we still overlooking the IV room?

January 28, 2015

Promethazine HCl (marketed as Phenergan) Information.

May 3, 2006

Benzocaine sprays marketed under different names, including Hurricaine, Topex, and Cetacaine.

February 22, 2006

Medicines in My Home.

August 2, 2006

AHRQ Health Literacy Universal Precautions Toolkit. 2nd edition.

July 1, 2015

Related Resources

ISMP survey on tall man (mixed case) lettering to reduce drug name confusion.

November 16, 2022

Using failure mode and effects analysis to increase patient safety in cancer chemotherapy.

December 22, 2021

FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy.

August 20, 2021

Dangerous wrong-route errors with tranexamic acid.

September 30, 2020

FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management.

November 28, 2018

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

October 10, 2018

Specifications of computerized provider order entry and clinical decision support systems for cancer patients undergoing chemotherapy: a systematic review.

October 10, 2018

Oncology nurses' beliefs and attitudes towards the double-check of chemotherapy medications: a cross-sectional survey study.

March 21, 2018

Instituting vincristine minibag administration: an innovative strategy using simulation to enhance chemotherapy safety.

December 6, 2017

Eliminating vincristine administration events.

November 29, 2017

Preventable and mitigable adverse events in cancer care: measuring risk and harm across the continuum.

September 6, 2017

Just Bag It.

November 30, 2016

Heparin-containing medical devices and combination products: recommendations for labeling and safety testing. Draft guidance for industry and Food and Drug Administration staff.

August 5, 2015

FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa (ceftolozane and tazobactam).

June 3, 2015

Mitigating errors caused by interruptions during medication verification and administration: interventions in a simulated ambulatory chemotherapy setting.

July 2, 2014

Improving cancer patient care with combined medication error reviews and morbidity and mortality conferences.

May 28, 2014

Caregivers' perception of drug administration safety for pediatric oncology patients.

April 16, 2014

Identifying systems failures in the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids.

April 9, 2014

Medication safety and the administration of intravenous vincristine: international survey of oncology pharmacists.

February 26, 2014

Intrathecal chemotherapy: potential for medication error.

December 4, 2013

Impact of electronic chemotherapy order forms on prescribing errors at an urban medical center: results from an interrupted time-series analysis.

November 6, 2013

Death and neurological devastation from intrathecal vinca alkaloids: prepared in syringes = 120; prepared in minibags = 0.

September 25, 2013

Kadcyla (ado-trastuzumab emtansine): drug safety communication—potential medication errors resulting from name confusion.

May 15, 2013

Important change to heparin container labels to clearly state the total drug strength.

December 19, 2012

2012 ISMP International Medication Safety Self Assessment for Oncology.

April 18, 2012

Smart pump custom concentrations without hard "low concentration" alerts.

March 14, 2012

Preventing Infections During Cancer Treatment.

November 16, 2011

Chemotherapy in home care: one team's performance improvement journey toward reducing medication errors.

October 12, 2011

WebM&M Cases

Central, not Epidural

September 1, 2011

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

See More About The Topic

Hospitals

Health Care Providers

Risk Managers

Medical Oncology

Infusion Pumps

FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Submit Your Innovations

Continue as a Guest

Continue Logged In

Submit Your Innovations

Continue as a Guest

Continue logged in

New Users to the PSNet site